🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
This Phase II, multicenter, randomized trial is designed to make preliminar...
Status
Completed
Location
Comprehensive Blood and Cancer Center (TORI)
Start Date
2004-07
Trial ID
NCT00095225
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
This trial will investigate the combination of bevacizumab, and erlotinib i...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00193622
Treatments Being Tested
This randomized phase I/II trial is to see if combining erlotinib with beva...
Status
Completed
Location
University of Chicago
Start Date
2003-03
Trial ID
NCT00055913
Treatments Being Tested
This study wants to determine the activity of a non chemotherapy first line...
Status
Completed
Location
Klinikum Bayreuth GmbH
Start Date
2007-11
Trial ID
NCT00536640
Treatments Being Tested
The main purpose of this research study is to collect information to learn ...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2006-10
Trial ID
NCT00392665
Treatments Being Tested
This single arm study evaluated the efficacy and safety of a combination of...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00605722
Treatments Being Tested
This is a Phase III, multicenter, placebo-controlled, double-blind, randomi...
Status
Completed
Location
Kaiser Permanente - Vallejo
Start Date
2005-06-08
Trial ID
NCT00130728
Treatments Being Tested